Naples, Italy

Vincenzo Di Marzo

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 110(Granted Patents)


Location History:

  • Napoli, IT (2013)
  • Pozzuoli, IT (2008 - 2019)
  • Cambridge, GB (2019)
  • Naples, IT (2007 - 2022)
  • Milan, IT (2016 - 2022)

Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Vincenzo Di Marzo: A Pioneer in Innovative Medical Solutions

Date: [Today's Date]

Introduction:

In the field of medical innovation and patenting, few names stand out like Vincenzo Di Marzo. Hailing from Naples, Italy, Di Marzo has made significant contributions with his 13 patents, focusing on groundbreaking treatments for pain caused by osteoarthritis, epithelial dysfunctions, and inflammatory skin diseases. Let's delve into his latest inventions and notable career achievements.

Patent 1: Use of a combination of Adelmidrol and hyaluronic acid in the treatment of pain caused by osteoarthritis and epithelial dysfunctions

One of Di Marzo's latest patents involves the application of Adelmidrol, a compound that increases the endogenous levels of Palmitoylethanolamide, in the treatment of pain caused by osteoarthritis and epithelial dysfunctions. By not inhibiting the activity of Palmitoylethanolamide-degrading enzymes, this innovative solution holds promise for improving patients' quality of life and restoring normal bodily functions.

Patent 2: Use of cannabinoids in the treatment of inflammatory skin diseases

Di Marzo's second notable patent focuses on the utilization of cannabinoids, such as cannabidiol (CBD) and cannabigerol (CBG), in treating inflammatory skin diseases. This inventive approach has the potential to revolutionize the treatment of conditions like microbial infection-induced dermatitis, solar dermatitis, atopic dermatitis, and allergic contact dermatitis.

Career and Collaborators:

Di Marzo's career has seen him contribute to esteemed companies in the industry, including Indena S.p.A and GW Pharma Limited. Indena S.p.A, a renowned Italian medical company, has been at the forefront of pharmaceutical research. GW Pharma Limited, a leading global biopharmaceutical company, has dedicated its efforts to the development of innovative cannabinoid-based medicinal products.

Throughout his career, Di Marzo has collaborated with noteworthy individuals in the field, including Colin Stott and Luciano De Petrocellis. Their collective expertise has undoubtedly played a pivotal role in the successful development and commercialization of his patented inventions.

Conclusion:

Vincenzo Di Marzo's impressive patent portfolio and his pioneering work in the medical field have solidified his position as an innovative force. Through his groundbreaking inventions targeting pain, epithelial dysfunctions, and inflammatory skin diseases, he has changed the landscape of medical treatments. As his career unfolds, we can anticipate further contributions from Di Marzo, as he continues to bring innovative solutions to the forefront of medical advancements.

For more information about Vincenzo Di Marzo, his patents, and other noteworthy inventors and companies, visit "idiyas.com."

Disclaimer: The information provided in this article is based on publicly available data and research. Any opinions expressed are those of the writer and do not necessarily reflect the views of idiyas.com.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…